End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support

E. Rombout-Sestrienkova, N. de Jonge, K. Martinakova, C. Klopping, K.P. van Galen, A. Vink, E.M. Wajon, W.M. Smit, C. van Bree, G.H. Koek

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)541-543
Number of pages3
JournalCirculation-Heart Failure
Volume7
Issue number3
DOIs
Publication statusPublished - May 2014

Keywords

  • dilated cardiomiopathy
  • erythrocytapheresis
  • hereditary hemochromatosis
  • left ventricular assist device
  • nonischemic cardiomiopathy
  • IRON-OVERLOAD
  • PHLEBOTOMY

Cite this